Results 11 to 20 of about 31,832 (242)

Karl Gustaf Torsten Sjögren and the Sjögren-Larsson syndrome [PDF]

open access: yesDermatology Reports, 2011
Karl Gustaf Torsten Sjögren (1896-1974) a Swedish psychiatrist and geneticist, was a pioneer of modern Swedish psychiatry. Sjögren studied medicine at the University of Uppsala.
Khalid Al Aboud, Daifullah Al Aboud
doaj   +4 more sources

Sjögren syndrome complicated by acute lymphoblastic leukemia [PDF]

open access: yesAmerican Journal of Experimental and Clinical Research, 2020
Malignant lymphoma is a well-recognized occurrence in Sjögren syndrome; however, progression to acute lymphoblastic leukemia is extremely uncommon. Here we present a patient with Sjögren syndrome complicated with acute lymphoblastic leukemia.
Fariba Binesh   +4 more
doaj   +2 more sources

Case Report: Streptococcus gordonii triggering suppurative parotitis and sepsis in a patient with Sjögren syndrome [PDF]

open access: yesFrontiers in Medicine
BackgroundAcute suppurative parotitis is common in primary Sjögren syndrome due to parotid gland dysfunction. Streptococcus gordonii is an aggressive pathogen but is rarely reported in acute suppurative parotitis.Case summaryA 64-year-old woman with ...
Ye Wang   +4 more
doaj   +2 more sources

Síndrome de Sjögren Sjögren syndrome [PDF]

open access: yesRevista Cubana de Medicina, 2010
Se realiza una revisión de las bases de datos a las que se puede acceder a través de Internet sobre temas de medicina, así como de las principales revistas y sitios que tratan sobre afecciones reumatológicas buscando los conceptos más actuales que se ...
José Pedro Martínez Larrarte   +1 more
doaj   +1 more source

Tinta: oboseala cronica din Sindromul Sjögren [PDF]

open access: yes, 2022
Oboseala cronica este o problema predominanta in Sjögren. Unul din doi pacienti cu Sjögren sufera de oboseala severa, cu efecte majore asupra vietii de zi cu zi.
Geenen, R.
core   +2 more sources

Accelerating Subcutaneous Drug Development: A Mechanistic Absorption Model for the Open Systems Pharmacology Framework. [PDF]

open access: yesCPT Pharmacometrics Syst Pharmacol
ABSTRACT This study describes the implementation of a mechanistic subcutaneous (SC) injection model for the Open Systems Pharmacology platform. As the SC route of administration is gaining increased popularity, there is a growing need for tools to predict, analyze, and understand the SC absorption process and the mechanisms involved.
Pellowe M, Dubbelboer I, Sjögren E.
europepmc   +2 more sources

Sjogren′s Syndrome: A Review

open access: yesJournal of Indian Academy of Oral Medicine and Radiology, 2011
Sjogren′s syndrome, also known as "Mikulicz disease" or "Sicca syndrome" is a systemic autoimmune disease in which immune cells attack and destroy the exocrine glands that produce tears and saliva.
Rani Somani   +3 more
doaj   +1 more source

PRİMER SJÖGREN SENDROMUNDA SEROLOJİK TETKİKLERİN TÜKRÜK BEZİ BİYOPSİ DERECESİ VE KLİNİK İLİŞKİSİNİN DEĞERLENDİRİLMESİ

open access: yesJournal of Contemporary Medicine, 2019
Giriş-Amaç: Sjögren sendromu göz yaşı ve tükrük bezleri olmak üzere tüm ekzokrin bezleri etkileyen kronik, sistemik otoimmün bir hastalıktır. Sjögren sendromu tanısında klinik ve seroimmünolojik testlerden faydalanılır.
Muhammet Limon   +4 more
doaj   +1 more source

A Sjögren-szindróma kórlefolyását befolyásoló tényezők vizsgálata [PDF]

open access: yes, 2021
A primer Sjögren-szindróma (pSS) heterogén klinikai megjelenést mutató szisztémás autoimmun kórkép. A diagnózis felállítása klasszifikációs kritériumrendszer használatával történik, amely a páciensek szubjektív és objektív glandularis tüneteit, a ...
Levko, Kamilla
core  

Sjögren Disease-B Cells at the Brink: From Autoimmunity to Lymphomagenesis and the Rise of Novel B Cell-Targeted Therapies. [PDF]

open access: yesArthritis Rheumatol
Sjögren disease (SjD) is a common systemic autoimmune disorder characterized by inflammation of the exocrine glands, resulting in dryness. Patients frequently exhibit extraglandular manifestations affecting various organ systems. To date, there are no US Food and Drug Administration (FDA)‐approved disease‐modifying therapies for SjD. In this review, we
Gordon RA, McCoy SS.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy